Clinical Trial Update: Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1 [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating inhaled treprostinil for pulmonary hypertension associated with COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• Tyvaso (treprostinil) (treprostinil)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Pulmonary Hypertension, COPD | Phase 1 | Status: COMPLETED